Carregant...
Potential Therapeutic Targets in Uterine Sarcomas
Uterine sarcomas are rare tumors accounting for 3,4% of all uterine cancers. Even after radical hysterectomy, most patients relapse or present with distant metastases. The very limited clinical benefit of adjuvant cytotoxic treatments is reflected by high mortality rates, emphasizing the need for ne...
Guardat en:
| Publicat a: | Sarcoma |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Hindawi Publishing Corporation
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4632006/ https://ncbi.nlm.nih.gov/pubmed/26576131 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/243298 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|